Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
青松股份
300132
5
川寧生物
301301
(Q1)2025/03/31 | (FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 22.29%1.19億 | 36.10%4.29億 | 32.25%1.17億 | 39.60%1.12億 | 39.09%1.03億 | 33.89%9,701萬 | -1.72%3.15億 | 7.93%8,869萬 | -1.85%8,047萬 | -7.31%7,375.8萬 |
營業收入 | 22.29%1.19億 | 36.10%4.29億 | 32.25%1.17億 | 39.60%1.12億 | 39.09%1.03億 | 33.89%9,701萬 | -1.72%3.15億 | 7.93%8,869萬 | -1.85%8,047萬 | -7.31%7,375.8萬 |
主營業務成本 | 11.07%5,807.4萬 | 30.73%2.19億 | 20.98%5,916.1萬 | 36.23%5,648.4萬 | 32.40%5,135.1萬 | 35.48%5,228.7萬 | 4.15%1.68億 | 15.80%4,890.2萬 | -1.59%4,146.2萬 | -1.52%3,878.5萬 |
毛利 | 35.42%6,056.4萬 | 42.21%2.1億 | 46.10%5,813.2萬 | 43.19%5,585.6萬 | 46.51%5,124萬 | 32.07%4,472.3萬 | -7.65%1.48億 | -0.40%3,978.8萬 | -2.14%3,900.8萬 | -12.99%3,497.3萬 |
營業費用 | 18.65%2,786.4萬 | 23.91%1.02億 | 18.89%2,683.2萬 | 31.42%2,621萬 | 26.52%2,535.5萬 | 19.40%2,348.5萬 | 4.93%8,222.1萬 | 15.83%2,256.9萬 | 3.75%1,994.3萬 | 3.74%2,004萬 |
銷售和管理費用 | 20.10%1,750.2萬 | 25.31%6,359.5萬 | 13.31%1,646.1萬 | 34.90%1,644萬 | 35.22%1,612.1萬 | 20.29%1,457.3萬 | 2.53%5,075.1萬 | 13.48%1,452.7萬 | -0.49%1,218.7萬 | 1.07%1,192.2萬 |
-銷售費用 | ---- | 30.46%4,813.4萬 | ---- | ---- | ---- | ---- | -3.54%3,689.6萬 | ---- | ---- | ---- |
-管理費用 | ---- | 11.59%1,546.1萬 | ---- | ---- | ---- | ---- | 23.16%1,385.5萬 | ---- | ---- | ---- |
研發費用 | 16.27%1,036.2萬 | 21.66%3,828.7萬 | 28.96%1,037.1萬 | 25.97%977萬 | 13.75%923.4萬 | 17.98%891.2萬 | 9.05%3,147萬 | 20.32%804.2萬 | 11.18%775.6萬 | 7.92%811.8萬 |
營業利潤 | 53.97%3,270萬 | 65.21%1.08億 | 81.78%3,130萬 | 55.50%2,964.6萬 | 73.34%2,588.5萬 | 49.62%2,123.8萬 | -19.74%6,541.2萬 | -15.84%1,721.9萬 | -7.61%1,906.5萬 | -28.46%1,493.3萬 |
淨非營業利息收入(費用) | -3.16%543.3萬 | 3.75%2,313.2萬 | 6.56%613.8萬 | 12.31%637萬 | -12.86%501.4萬 | 9.78%561萬 | 216.66%2,229.6萬 | 38.73%576萬 | 179.55%567.2萬 | 2,434.80%575.4萬 |
利息收入 | -3.16%543.3萬 | 3.28%2,484.1萬 | 4.42%784.7萬 | 12.31%637萬 | 7.79%620.2萬 | 9.78%561萬 | 178.11%2,405.1萬 | 30.49%751.5萬 | 179.55%567.2萬 | 2,434.80%575.4萬 |
利息費用 | ---- | 0.00%109.4萬 | ---- | ---- | ---- | ---- | 0.00%109.4萬 | ---- | ---- | ---- |
其他財務費用 | ---- | -6.96%61.5萬 | ---- | ---- | ---- | ---- | 28.85%66.1萬 | ---- | ---- | ---- |
其他淨收入(費用) | 147.44%3.7萬 | 77.78%-7.8萬 | ||||||||
出售證券收益 | ---- | 147.44%3.7萬 | ---- | ---- | ---- | ---- | 77.78%-7.8萬 | ---- | ---- | ---- |
稅前利潤 | 42.03%3,813.3萬 | 49.76%1.31億 | 63.64%3,747.5萬 | 45.60%3,601.6萬 | 49.36%3,089.9萬 | 39.07%2,684.8萬 | -0.63%8,763萬 | -5.61%2,290.1萬 | 9.14%2,473.7萬 | -1.97%2,068.7萬 |
所得稅 | 86.53%382.2萬 | 41.40%1,272.3萬 | 111.56%446.6萬 | 22.17%327.3萬 | 36.64%293.5萬 | -0.53%204.9萬 | 9.21%899.8萬 | -18.46%211.1萬 | 37.38%267.9萬 | 11.93%214.8萬 |
除稅後利潤 | 38.36%3,431.1萬 | 50.72%1.19億 | 58.77%3,300.9萬 | 48.44%3,274.3萬 | 50.84%2,796.4萬 | 43.80%2,479.9萬 | -1.65%7,863.2萬 | -4.07%2,079萬 | 6.48%2,205.8萬 | -3.36%1,853.9萬 |
持續經營利潤 | 38.36%3,431.1萬 | 50.72%1.19億 | 58.77%3,300.9萬 | 48.44%3,274.3萬 | 50.84%2,796.4萬 | 43.80%2,479.9萬 | -1.65%7,863.2萬 | -4.07%2,079萬 | 6.48%2,205.8萬 | -3.36%1,853.9萬 |
歸屬於少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | 38.36%3,431.1萬 | 50.72%1.19億 | 58.77%3,300.9萬 | 48.44%3,274.3萬 | 50.84%2,796.4萬 | 43.80%2,479.9萬 | -1.65%7,863.2萬 | -4.07%2,079萬 | 6.48%2,205.8萬 | -3.36%1,853.9萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | 38.36%3,431.1萬 | 50.72%1.19億 | 58.77%3,300.9萬 | 48.44%3,274.3萬 | 50.84%2,796.4萬 | 43.80%2,479.9萬 | -1.65%7,863.2萬 | -4.07%2,079萬 | 6.48%2,205.8萬 | -3.36%1,853.9萬 |
基本每股收益 | 36.36%0.75 | 48.86%2.62 | 58.70%0.73 | 44.90%0.71 | 47.62%0.62 | 41.03%0.55 | -2.76%1.76 | -6.12%0.46 | 4.26%0.49 | -4.55%0.42 |
稀釋每股收益 | 37.25%0.7 | 48.47%2.42 | 59.52%0.67 | 45.65%0.67 | 50.00%0.57 | 41.67%0.51 | -2.98%1.63 | -6.67%0.42 | 6.98%0.46 | -5.00%0.38 |
每股派息 | 0 | 1.33 | 0 | 0 | 0 | 1.33 | 0 | 0 | 0 | 0 |
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | -- | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- | -- |